HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 83 filers reported holding HARVARD BIOSCIENCE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,017,711 | -19.5% | 236,677 | +2.8% | 0.00% | – |
| Q2 2023 | $1,264,018 | +98.9% | 230,240 | +52.1% | 0.00% | – |
| Q1 2023 | $635,636 | +51.6% | 151,342 | 0.0% | 0.00% | – |
| Q4 2022 | $419,217 | -16.8% | 151,342 | -23.1% | 0.00% | – |
| Q3 2022 | $504,000 | -28.9% | 196,795 | 0.0% | 0.00% | – |
| Q2 2022 | $709,000 | -57.1% | 196,795 | -26.1% | 0.00% | – |
| Q1 2022 | $1,654,000 | +11.8% | 266,192 | +26.8% | 0.00% | – |
| Q4 2021 | $1,480,000 | +1.0% | 209,871 | 0.0% | 0.00% | – |
| Q3 2021 | $1,465,000 | -14.9% | 209,871 | +1.6% | 0.00% | -100.0% |
| Q2 2021 | $1,722,000 | +229.9% | 206,655 | +116.4% | 0.00% | – |
| Q1 2021 | $522,000 | +37.4% | 95,486 | +7.9% | 0.00% | – |
| Q4 2020 | $380,000 | +42.3% | 88,528 | 0.0% | 0.00% | – |
| Q3 2020 | $267,000 | -2.9% | 88,528 | 0.0% | 0.00% | – |
| Q2 2020 | $275,000 | -18.4% | 88,528 | -19.1% | 0.00% | – |
| Q3 2019 | $337,000 | +53.9% | 109,416 | 0.0% | 0.00% | – |
| Q2 2019 | $219,000 | -32.4% | 109,416 | +45.6% | 0.00% | – |
| Q1 2019 | $324,000 | +20.0% | 75,167 | -11.5% | 0.00% | – |
| Q4 2018 | $270,000 | -39.5% | 84,892 | 0.0% | 0.00% | – |
| Q3 2018 | $446,000 | +21.5% | 84,892 | +23.8% | 0.00% | – |
| Q2 2018 | $367,000 | +278.4% | 68,592 | +255.4% | 0.00% | – |
| Q1 2018 | $97,000 | +51.6% | 19,300 | 0.0% | 0.00% | – |
| Q4 2017 | $64,000 | -12.3% | 19,300 | 0.0% | 0.00% | – |
| Q3 2017 | $73,000 | +46.0% | 19,300 | 0.0% | 0.00% | – |
| Q2 2017 | $50,000 | -2.0% | 19,300 | 0.0% | 0.00% | – |
| Q1 2017 | $51,000 | -13.6% | 19,300 | 0.0% | 0.00% | – |
| Q4 2016 | $59,000 | +11.3% | 19,300 | 0.0% | 0.00% | – |
| Q3 2016 | $53,000 | -5.4% | 19,300 | 0.0% | 0.00% | – |
| Q2 2016 | $56,000 | -80.4% | 19,300 | -79.5% | 0.00% | – |
| Q1 2016 | $285,000 | -12.8% | 94,229 | 0.0% | 0.00% | – |
| Q4 2015 | $327,000 | -8.4% | 94,229 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $357,000 | +4.1% | 94,229 | +57.0% | 0.00% | – |
| Q2 2015 | $343,000 | +203.5% | 60,029 | +211.0% | 0.00% | – |
| Q1 2015 | $113,000 | +2.7% | 19,300 | 0.0% | 0.00% | – |
| Q4 2014 | $110,000 | +39.2% | 19,300 | 0.0% | 0.00% | – |
| Q3 2014 | $79,000 | -10.2% | 19,300 | 0.0% | 0.00% | – |
| Q2 2014 | $88,000 | -63.0% | 19,300 | -61.5% | 0.00% | – |
| Q1 2014 | $238,000 | +0.8% | 50,100 | 0.0% | 0.00% | – |
| Q4 2013 | $236,000 | -10.6% | 50,100 | 0.0% | 0.00% | -100.0% |
| Q3 2013 | $264,000 | +10.5% | 50,100 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $239,000 | – | 50,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |